首页> 美国卫生研究院文献>Frontiers in Pediatrics >Prescribing Controversies: An Updated Review and Meta-Analysis on Combined/Alternating Use of Ibuprofen and Paracetamol in Febrile Children
【2h】

Prescribing Controversies: An Updated Review and Meta-Analysis on Combined/Alternating Use of Ibuprofen and Paracetamol in Febrile Children

机译:处方争议:高热儿童布洛芬和扑热息痛联合/替代使用的最新综述和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Ibuprofen and paracetamol are the only antipyretics recommended in febrile children. According to international guidelines the choice of the drug should rely on the child's individual characteristics, while a controversial issue regards the combined or alternate use of the two drugs.>Objective: To compare the efficacy and safety of combined or alternating use of ibuprofen and paracetamol in children.>Methods: A systematic review of literature was performed on Medline and Embase databases. The included studies were randomized controlled trials analyzing the efficacy of combined or alternating therapy with antipyretics in febrile children vs. monotherapy. A meta-analysis was performed to measure the effect of treatment on child's temperature and discomfort. Adverse effects were analyzed as secondary outcome.>Results: Nine studies were included, involving 2,026 children. Mean temperature was lower in the combined therapy group at 1 h (mean difference: −0.29°C; 95%CI: −0.45 to −0.13) after the initial administration of therapy. No statistical difference was found in mean temperature at 4 and 6 h from baseline. A significant difference was found in the proportion of children reaching apyrexia at 4 and 6 h with the combined treatment (RR: 0.18, 95%CI: 0.06 to 0.53, and 0.10, 95%CI: 0.01–0.71, respectively) and at 6 h with alternating treatment (RR: 0.30, 95% CI: 0.15–0.57), compared to children treated with monotherapy. The child's discomfort score was slightly lower with alternating therapy vs. monotherapy. The pooled mean difference in the number of medication doses per child used during the first 24 h was not significantly different among groups.>Discussion: Combined or alternating therapy resulted more effective than monotherapy in reducing body temperature. However, the benefit appeared modest and probably not clinically relevant. The effect on child discomfort and number of doses of medication was modest as well. According to our findings, evidences are not robust enough to encourage combined or alternating paracetamol and ibuprofen instead of monotherapy to treat febrile children, reinforcing the current recommendation of most of the international guidelines.
机译:>背景:布洛芬和扑热息痛是高热儿童中推荐的唯一退热药。根据国际准则,药物的选择应取决于孩子的个人特征,而有争议的问题则是两种药物联合使用或替代使用的问题。>目的:比较联合或联合使用的有效性和安全性在儿童中交替使用布洛芬和扑热息痛。>方法:在Medline和Embase数据库上进行了系统的文献综述。纳入的研究是随机对照试验,分析了退热药联合或交替治疗退热药与单药治疗的疗效。进行荟萃分析以衡量治疗对儿童体温和不适的影响。分析不良反应作为次要结果。>结果:纳入了9项研究,涉及2,026名儿童。初次给予治疗后1 h,联合治疗组的平均温度较低(平均差:-0.29°C; 95%CI:-0.45至-0.13)。与基线相比,第4和6小时的平均温度没有统计学差异。发现在联合治疗下4和6小时达到无热的儿童的比例有显着差异(分别为RR:0.18、95%CI:0.06至0.53和0.10、95%CI:0.01–0.71)和6与接受单药治疗的儿童相比,交替治疗h(RR:0.30,95%CI:0.15–0.57)。与单一疗法相比,交替疗法的儿童不适感评分略低。各组之间在开始的24小时内每个孩子使用的药物剂量的汇总平均差异在各组之间没有显着差异。>讨论:联合或交替治疗比降温治疗更有效。但是,获益似乎不大,可能与临床无关。对儿童不适和药物剂量的影响也中等。根据我们的发现,证据不足以鼓励对乙酰氨基酚和布洛芬联合或交替使用,而不是单一疗法来治疗高热儿童,这加强了目前大多数国际指南的建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号